Fresh Tracks Therapeutics Analysis

Fresh Pink Sheet Analysis Notes

The company has price-to-book (P/B) ratio of 0.45. Some equities with similar Price to Book (P/B) outperform the market in the long run. Fresh Tracks Therapeutics recorded a loss per share of 2.32. The entity last dividend was issued on the 3rd of September 2019. The firm had 1:45 split on the 5th of July 2022. Fresh Tracks Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States. Fresh Tracks Therapeutics, Inc. was founded in 2009 and is headquartered in Boulder, Colorado. Fresh Tracks operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 16 people.The quote for Fresh Tracks Therapeutics is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To learn more about Fresh Tracks Therapeutics call Attorney Brown at 720 505 4755 or check out https://www.frtx.com.

Fresh Tracks Therapeutics Investment Alerts

Fresh Tracks Therapeutics Upcoming and Recent Events

Fresh Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 4.84 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Fresh Tracks's market, we take the total number of its shares issued and multiply it by Fresh Tracks's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Fresh Profitablity

The company has Profit Margin (PM) of (0.89) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.25 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.25.

Fresh Tracks Predictive Daily Indicators

Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Fresh Tracks prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Fresh shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Fresh Tracks. By using and applying Fresh Pink Sheet analysis, traders can create a robust methodology for identifying Fresh entry and exit points for their positions.

Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

If you are still planning to invest in Fresh Tracks Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Fresh Tracks' history and understand the potential risks before investing.